GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hologic Inc (FRA:HO1) » Definitions » Cyclically Adjusted PS Ratio

Hologic (FRA:HO1) Cyclically Adjusted PS Ratio : 4.54 (As of May. 22, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hologic Cyclically Adjusted PS Ratio?

As of today (2024-05-22), Hologic's current share price is €68.50. Hologic's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €15.08. Hologic's Cyclically Adjusted PS Ratio for today is 4.54.

The historical rank and industry rank for Hologic's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:HO1' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.93   Med: 4.74   Max: 7.36
Current: 4.58

During the past years, Hologic's highest Cyclically Adjusted PS Ratio was 7.36. The lowest was 2.93. And the median was 4.74.

FRA:HO1's Cyclically Adjusted PS Ratio is ranked worse than
67.58% of 475 companies
in the Medical Devices & Instruments industry
Industry Median: 2.2 vs FRA:HO1: 4.58

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Hologic's adjusted revenue per share data for the three months ended in Mar. 2024 was €3.942. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €15.08 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hologic Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Hologic's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hologic Cyclically Adjusted PS Ratio Chart

Hologic Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.03 6.13 5.76 4.34 4.38

Hologic Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.25 5.18 4.38 4.49 4.77

Competitive Comparison of Hologic's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Hologic's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hologic's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hologic's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hologic's Cyclically Adjusted PS Ratio falls into.



Hologic Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Hologic's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=68.50/15.08
=4.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hologic's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Hologic's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=3.942/131.7762*131.7762
=3.942

Current CPI (Mar. 2024) = 131.7762.

Hologic Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.668 100.560 2.186
201409 1.772 100.428 2.325
201412 1.870 99.070 2.487
201503 2.106 99.621 2.786
201506 2.113 100.684 2.766
201509 2.124 100.392 2.788
201512 2.186 99.792 2.887
201603 2.163 100.470 2.837
201606 2.262 101.688 2.931
201609 2.293 101.861 2.966
201612 2.450 101.863 3.169
201703 2.339 102.862 2.996
201706 2.494 103.349 3.180
201709 2.366 104.136 2.994
201712 2.381 104.011 3.017
201803 2.310 105.290 2.891
201806 2.560 106.317 3.173
201809 2.556 106.507 3.162
201812 2.681 105.998 3.333
201903 2.690 107.251 3.305
201906 2.786 108.070 3.397
201909 2.924 108.329 3.557
201912 2.838 108.420 3.449
202003 2.587 108.902 3.130
202006 2.799 108.767 3.391
202009 4.345 109.815 5.214
202012 5.055 109.897 6.061
202103 4.953 111.754 5.840
202106 3.750 114.631 4.311
202109 4.342 115.734 4.944
202112 5.084 117.630 5.695
202203 5.139 121.301 5.583
202206 3.748 125.017 3.951
202209 3.812 125.227 4.011
202212 4.068 125.222 4.281
202303 3.838 127.348 3.971
202306 3.680 128.729 3.767
202309 3.584 129.860 3.637
202312 3.867 129.419 3.937
202403 3.942 131.776 3.942

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hologic  (FRA:HO1) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Hologic Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Hologic's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hologic (FRA:HO1) Business Description

Traded in Other Exchanges
Address
250 Campus Drive, Marlborough, MA, USA, 01752
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Hologic (FRA:HO1) Headlines

No Headlines